相关实验视频

Updated: Sep 9, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

通过CRISPR-Cas13d对特定环境的关键基因进行向,可选择性消除卵膜黑色素瘤

Daniel Stauber^1,2, Lucas Sosnick^1,2, Yitong Ma¹

¹Department of Bioengineering, Stanford University, Stanford, CA, USA.

bioRxiv : the preprint server for biology

|September 2, 2025

概括

研究人员开发了一种使用CRISPR-Cas13d的新型RNA向治疗方法,以静止皮膜黑色素瘤中必不可少的RASGRP3基因. 这项突破为这种侵袭性眼癌提供了强有力的新疗法,

科学领域:

癌症学
分子生物学
基因治疗

背景情况:

卵巢黑色素瘤是最常见的成年人眼癌,治疗选择有限,存活率低.
在过去的50年里, 手术和化疗等现有疗法几乎没有得到改善.
RASGRP3被确定为一种关键基因,对膜黑色素瘤的存活至关重要,但在健康细胞中没有.

研究的目的:

开发一种针对无药性RASGRP3的新疗法.
研究CRISPR-Cas13dRNA向系统对膜黑色素瘤的疗效.
建立基于Cas13d的疗法用于其他难以治疗的癌症的框架.

主要方法:

对公共基因表达,RNAi和CRISPR淘汰数据集的系统分析.
开发一种针对CRISPR-Cas13dRNA的治疗方法,以击败RASGRP3mRNA.
通过优化的脂质纳米颗粒传递Cas13d mRNA和引导RNA.

主要成果:

CRISPR- Cas13d疗法可以选择性地消除超过97%的皮膜黑色素瘤细胞.
该疗法通过协同机制起作用:直接抑制RASGRP3和附带RNA降解.
与Cas9和siRNA相比,这种方法显示出更高的功效,而不会引起基因组变化.

结论:

一种使用CRISPR-Cas13d的新型RNA向治疗方法已被确立用于皮膜黑色素瘤.
这种策略有效地准了以前无法治疗的RASGRP3基因.
这些发现为开发基于Cas13d的各种癌症治疗提供了基础.

关键词:

在CRISPR-Cas13d中对RNA进行向治疗癌症的药物特定环境的基本基因精确瘤准皮膜黑色素瘤

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Published on: June 16, 2017

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.